lung and sinus NDC 69779-007

NDC codes

FDA NDC Directory

Product NDC (as listed)69779-007Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69779-0007Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69779-007-01	69779000701	1 BOTTLE in 1 CARTON (69779-007-01) / 29.6 mL in 1 BOTTLEMarketed from Apr 9, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): lung and sinus
Generic name (nonproprietary): calc phos, ferrum phos, gentianella amarella, flos, kali mur, kali phos, kali sulph, rock water, rose canina, flos
Active ingredients: Tribasic calcium phosphate — 12 [hp_X]/29.6mLFerrosoferric phosphate — 12 [hp_X]/29.6mLGentianella amarella flower — 5 [hp_X]/29.6mLPotassium chloride — 6 [hp_X]/29.6mLPotassium phosphate, Dibasic — 6 [hp_X]/29.6mLPotassium sulfate — 6 [hp_X]/29.6mLWater — 5 [hp_X]/29.6mLRosa canina flower — 5 [hp_X]/29.6mL
Dosage form: Spray
Route: Oral
Labeler: Siddha Flower Essences LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Apr 9, 2015
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)
Identifiers: Product ID 69779-007_474d3148-8975-ed37-e063-6394a90a6ac2SPL ID 474d3148-8975-ed37-e063-6394a90a6ac2SPL set ID 9f7c949f-21bc-473c-ab8d-24837893fcccUNII 91D9GV0Z28, 91GQH8I5F7, ZKH2SOY1AR, 660YQ98I10, CI71S98N1Z, 1K573LC5TV, 059QF0KO0R, 81MCR2UQ6QUPC 0897186002115
Pharmacologic class: Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469779000701 followed by a unit qualifier and the quantity

Package 69779-0007-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 31, 2025.

Indications (excerpt from the label)

Uses temporarily relieves symptoms of cough stuffy head runny nose congestion of lungs thick mucus sadness indications are based on homeopathic materia medica, not clinical tests.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)